Company: BOLT
Filing Date: 2025-03-24
Form Type: 10-K
Source: 0000950170-25-043873
Chunk: 225

Company: Bolt Biotherapeutics, Inc.
Filing Date: 2025-03-24
Form: 10-K
Item: Item 8
Chunk 225
---
 independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits of these financial statements in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion. 

/s/ PricewaterhouseCoopers LLP 

San Jose, California

March 24, 2025

We have served as the Company’s auditor since 2019.

88

Table of Contents

BOLT BIOTHERAPEUTICS, INC. 

CONSOLIDATED BALANCE SHEETS 

(in thousands, except share and per share amounts) 

    December 31,

    2024

    2023

    Assets

    Current assets:

    Cash and cash equivalents
     
    $
    7,205

    $
    10,810

    Short-term investments

    40,118

    91,379

    Restricted cash

    784

    —

    Prepaid expenses and other current assets

    2,707

    3,519

    Total current assets

    50,814

    105,708

    Property and equipment, net

    3,139

    4,957

    Operating lease right-of-use assets

    21,756

    19,120

    Restricted cash, non-current

    981

    1,765

    Long-term investments

    22,880

    26,413

    Other